Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Niraj Babu, Mohd Younis Bhat, Arivusudar Everad John & Aditi Chatterjee. (2021) The role of proteomics in the multiplexed analysis of gene alterations in human cancer. Expert Review of Proteomics 18:9, pages 737-756.
Read now
Read now
Jorge Cortes, Lynn Huynh, Estella Mendelson, Patricia Brandt, Darshan Dalal, Maral DerSarkissian, Diego Cortina, Sahil Narkhede & Mei Sheng Duh. (2020) Treatment patterns and deep molecular response in chronic phase – chronic myeloid leukemia patients treated with second-line nilotinib or dasatinib: a multi-country retrospective chart review study. Leukemia & Lymphoma 61:1, pages 98-107.
Read now
Read now
Seung Hun Han, Sovannarith Korm, Ye Gi Han, Soo-Young Choi, Soo-Hyun Kim, Hee Jin Chung, Kibeom Park, Jae-Young Kim, Kyungjae Myung, Joo-Yong Lee, Hongtae Kim & Dong-Wook Kim. (2019) GCA links TRAF6-ULK1-dependent autophagy activation in resistant chronic myeloid leukemia. Autophagy 15:12, pages 2076-2090.
Read now
Read now
Articles from other publishers (17)
Moshe Levy, Lin Xie, Yuexi Wang, Frank Neumann, Shouryadeep Srivastava, Daniel Naranjo, Jing Xu, Qisu Zhang & Mehul Dalal. (2021) Comparison of incidence/occurrence of cardiovascular events between ponatinib vs bosutinib among patients with at least one prior line of tyrosine kinase inhibitors in chronic myeloid leukemia in a community setting in the United States. Cancer Treatment and Research Communications 28, pages 100424.
Crossref
Crossref
Carsten Riether, Ramin Radpour, Nils M. Kallen, Damian T. Bürgin, Chantal Bachmann, Christian M. Schürch, Ursina Lüthi, Miroslav Arambasic, Sven Hoppe, Christoph E. Albers, Gabriela M. Baerlocher & Adrian F. Ochsenbein. (2021) Metoclopramide treatment blocks CD93-signaling-mediated self-renewal of chronic myeloid leukemia stem cells. Cell Reports 34:4, pages 108663.
Crossref
Crossref
Farjah H. Algahtani & Fatmah S. Alqahtany. (2020) Evaluation and characterisation of Chronic myeloid leukemia and various treatments in Saudi Arabia: A retrospective study. Journal of Infection and Public Health 13:2, pages 295-298.
Crossref
Crossref
Sergio Pina-Oviedo, Haitham A. Khogeer, Guilin Tang & Roberto N. Miranda. 2020. Oncological Surgical Pathology. Oncological Surgical Pathology
1729
2141
.
Giovanni Carapezza, Carlo Cusi, Ettore Rizzo, Laura Raddrizzani, Sebastiano Di Bella, Alessio Somaschini, Antonella Leone, Rosita Lupi, Margherita Mutarelli, Vincenzo Nigro, Diego di Bernardo, Paolo Magni, Antonella Isacchi & Roberta Bosotti. (2019) Comprehensive kinome NGS targeted expression profiling by KING-REX. BMC Genomics 20:1.
Crossref
Crossref
Justin T. Brown, Ion J. Beldorth, Walairat Laosinchai-Wolf, Marie E. Fahey, Keri L. Jefferson, Adam K. Ruskin, Jacquelyn J. Roth, Li Cai, Christopher D. Watt, Richard D. Press, Fei Yang, John B. Hedges & Bernard F. Andruss. (2019) Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA. The Journal of Molecular Diagnostics 21:4, pages 718-733.
Crossref
Crossref
Nikki K. Lytle, Alison G. Barber & Tannishtha Reya. (2018) Stem cell fate in cancer growth, progression and therapy resistance. Nature Reviews Cancer 18:11, pages 669-680.
Crossref
Crossref
Alejandro Zulbaran-Rojas, Huei-Kan Lin, Qiuling Shi, Loretta A. Williams, Binsah George, Guillermo Garcia-Manero, Elias Jabbour, Susan O’Brien, Farhad Ravandi, William Wierda, Zeev Estrov, Gautam Borthakur, Tapan Kadia, Charles Cleeland, Jorge E. Cortes & Hagop Kantarjian. (2018) A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second- and third-generation tyrosine kinase inhibitors. Cancer Medicine 7:11, pages 5457-5469.
Crossref
Crossref
Valérie Paris. (2018) Le coût des anti-cancéreux : un défi pour les systèmes de santé des pays de l’OCDE. Bulletin de l'Académie Nationale de Médecine 202:5-6, pages 989-1002.
Crossref
Crossref
Hayder Al-kuraishy, Ali Al-Gareeb & Ali Al-Buhadilly. (2018) p53 Gene (NY-CO-13) Levels in Patients with Chronic Myeloid Leukemia: The Role of Imatinib and Nilotinib. Diseases 6:1, pages 13.
Crossref
Crossref
Xiaohui Chang, Lin Zhou, Xiaoxia Chen, Baoli Xu, Yubin Cheng, Shujun Sun, Meiyun Fang & Yang Xiang. (2017) Impact of Imatinib on the Fertility of Male Patients with Chronic Myelogenous Leukaemia in the Chronic Phase. Targeted Oncology 12:6, pages 827-832.
Crossref
Crossref
Sócrates Avilés-Vázquez, Antonieta Chávez-González, Alfredo Hidalgo-Miranda, Dafne Moreno-Lorenzana, Lourdes Arriaga-Pizano, Miguel Á. Sandoval-Esquivel, Manuel Ayala-Sánchez, Rafael Aguilar, Luis Alfaro-Ruiz & Hector Mayani. (2017) Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib. Cancer Medicine 6:12, pages 2942-2956.
Crossref
Crossref
Swati DasguptaUjjal K RayArpita Ghosh MitraDeboshree M. BhattacharyyaAshis MukhopadhyayPriyabrata DasSudeshna GangopadhyaySudip RoySoma Mukhopadhyay. (2017) Evaluation of a new flow cytometry based method for detection of BCR-ABL1 fusion protein in chronic myeloid leukemia. Blood Research 52:2, pages 112.
Crossref
Crossref
Ross Kinstrie, Dimitris Karamitros, Nicolas GoardonHeather MorrisonMike HamblinLisa RobinsonRichard E. Clark, Mhairi Copland & Paresh Vyas. (2016) Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia. Blood Advances 1:3, pages 160-169.
Crossref
Crossref
Kalubai Vari Khajapeer & Rajasekaran Baskaran. (2015) Hsp90 Inhibitors for the Treatment of Chronic Myeloid Leukemia. Leukemia Research and Treatment 2015, pages 1-16.
Crossref
Crossref
Oren Pasvolsky, Avi Leader, Zaza Iakobishvili, Yishay Wasserstrum, Ran Kornowski & Pia Raanani. (2015) Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia. Cardio-Oncology 1:1.
Crossref
Crossref
Mariko Yoshimura, Kensuke Kojima, Rika Tomimasu, Noriyasu Fukushima, Shinichiro Hayashi, Eisaburo Sueoka & Shinya Kimura. (2014) ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia. International Journal of Hematology 100:6, pages 611-614.
Crossref
Crossref